Botulinum toxin in paediatric urology: A systematic literature review

Pediatric Surgery International

Volumn 25, Issue 1, 2009, Pages 19-23

  DasGupta, Ranan ^a   Murphy, Feilim Liam ^b  

^a GUY S HOSPITAL   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Bladder; Botulinum toxin; Intravesical; Paediatric; Sphincter; Voiding

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B;

ABSENCE OF SIDE EFFECTS; CHILD UROLOGY; DRUG EFFICACY; DRUG SAFETY; HUMAN; LONG TERM CARE; MICTURITION; MICTURITION DISORDER; MUSCLE WEAKNESS; OVERACTIVE BLADDER; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; URINARY URGENCY;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; CHILD; CYSTOSCOPY; HUMANS; INJECTIONS; URINARY BLADDER, NEUROGENIC; URINARY BLADDER, OVERACTIVE;

EID: 57649155708     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-008-2260-3     Document Type: Review

References (38)

1. B Schurch 2006 Botulinum toxin for the management of bladder dysfunction Drugs 66 1301 1318 10.2165/00003495-200666100-00001
2. DD Dykstra AA Sidi AB Scott 1988 Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients J Urol 139 919 922
3. MW Phelan M Franks GT Somogyi 2001 Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction J Urol 165 1107 1110 10.1016/S0022-5347(05)66438-5
4. CP Smith P Radziszewski A Borkowski 2004 Botulinum toxin A has antinociceptive effects in treating interstitial cystitis Urology 64 871 875 10.1016/j.urology.2004.06.073
5. D Zermann M Ishigooka J Schubert RA Schmidt 2000 Perisphincteric injection of botulinum toxin type A. A treatment option for patients with chronic prostatic pain? Eur Urol 38 393 399 10.1159/000020314
6. YC Chuang MB Chancellor 2006 The application of botulinum toxin in the prostate J Urol 176 2375 2382 10.1016/j.juro.2006.07.127
7. B Schurch J Corcos 2005 Botulinum toxin injections for paediatric incontinence Curr Opin Urol 15 264 267 10.1097/01.mou.0000172401.92761.86
8. A de Paiva FA Meunier J Molgo 1999 Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals Proc Natl Acad Sci USA 96 3200 3205 10.1073/pnas.96.6.3200
9. A Apostolidis P Dasgupta CJ Fowler 2006 Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity Eur Urol 49 644 650 10.1016/j.eururo.2005.12.010
10. CM Brady A Apostolidis M Harper 2004 Parallel changes in bladder suburothelial vanilloid receptor TRPV1 (VR1) and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity (NDO) following intravesical resiniferatoxin treatment BJUI 93 770 776 10.1111/j.1464-410X.2003.04722.x
11. A Apostolidis RB Popat Y Yiangou 2005 Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibres following intra-detrusor injections of Botulinum toxin for human detrusor overactivity J Urol 174 977 983 10.1097/01.ju.0000169481.42259.54
12. M Khera GT Somogyi S Kiss 2004 Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury Neurochem Int 45 987 993 10.1016/j.neuint.2004.06.001
13. OJ Wiseman CJ Fowler DN Landon 2003 The role of the human bladder lamina propria myofibroblast BJUI 91 89 93 10.1046/j.1464-410X.2003.03802.x
14. M Lagou MJ Drake M Markerink-van Ittersum 2006 Interstitial cells and phasic activity in the isolated mouse bladder BJUI 98 643 650
15. MJ Welch JR Purkiss KA Foster 2000 Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins Toxicon 38 245 258 10.1016/S0041-0101(99)00153-1
16. M Cui S Khanijou J Rubino KR Aoki 2004 Subcutaneous adminstration of botulinum toxin A reduces formalin-induced pain Pain 107 125 133 10.1016/j.pain.2003.10.008
17. A Reitz P Denys C Fermnanian B Schurch 2007 Do repeat intradetrusor botulinum toxin type A injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity Eur Urol 52 1729 1735 10.1016/j.eururo.2007.08.052
18. B Schurch M Stohrer G Kramer 2000 Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results J Urol 164 692 697 10.1016/S0022-5347(05)67283-7
19. A Reitz M Stohrer G Kramer 2004 European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity Eur Urol 45 510 515 10.1016/j.eururo.2003.12.004
20. B Schurch M de Seze P Denys 2005 Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo-controlled 6-month study J Urol 174 196 200 10.1097/01.ju.0000162035.73977.1c
21. A Sahai MS Khan P Dasgupta 2007 Efficacy of botulinum toxin-A for treating detrusor overactivity: results from a single center, randomized, double-blind, placebo-controlled trial J Urol 177 2231 2236 10.1016/j.juro.2007. 01.130
22. DJ Unwala P Barboglio AE Gousse 2007 Repeated botulinum toxin injection for idiopathic overactive bladder: will chemodenervation become a long-term solution? Curr Urol Rep 8 419 424 10.1007/s11934-007-0041-5
23. HU Ahmed IS Shergill M Arya PJR Shah 2006 Management of detrusor-external sphincter dyssynergia Nat Clin Pract Urol 3 368 380 10.1038/ncpuro0521
24. M Harper RB Popat R DasGupta 2003 A minimally invasive technique for outpatient local anaesthetic adminstration of intradetrusor botulinum toxin in intractable detrusor overactivity BJUI 92 325 326 10.1046/j.1464-410X.2003. 04312.x
25. G Karsenty P Denys G Amarenco 2008 Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/ neurogenic overactive bladder: a systematic literature review Eur Urol 53 275 287 10.1016/j.eururo.2007.10.013
26. H Schulte-Baukloh T Michael J Schobert 2002 Efficacy of botulinum A toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results Urology 59 325 327 10.1016/S0090-4295(01)01641-7
27. H Schulte-Baukloh T Michael B Stürzebecher 2003 Botulinum-a toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder Eur Urol 44 139 143 10.1016/S0302-2838(03) 00136-2
28. M Riccabona M Koen M Schindler 2004 Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia J Urol 171 845 848 10.1097/01.ju.0000108892.35041.2d
29. W Altaweel R Jednack C Bilodeau J Corcos 2006 Repeated intradetrusor botulinum toxin type A in children with neurogenic bladder due to myelomeningocele J Urol 175 1102 1105 10.1016/S0022-5347(05)00400-3
30. AM Kajbafzadeh S Moosavi P Tajik 2006 Intravesical injection of botulinum toxin type A: management of neuropathic bladder and bowel dysfunction in children with myelomeningocele Urology 68 1091 1096 10.1016/j.urology.2006.05. 056
31. M Akbar R Abel TM Seyler 2007 Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction BJUI 100 639 645 10.1111/j.1464-410X.2007. 06977.x
32. KF Neel S Soliman M Salem 2007 Botulinum-A toxin: solo treatment for neuropathic noncompliant bladder J Urol 178 2593 2598 10.1016/j.juro.2007.08.032
33. V Kalsi RB Popat A Apostolidis 2006 Cost-consequence analysis evaluating the use of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centre Eur Urol 49 519 527 10.1016/j.eururo.2005.11.006
34. P Hoebeke K De Caestecker J Vande Walle 2006 The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor J Urol 176 328 331 10.1016/S0022-5347(06)00301-6
35. FJ Hinman 1986 Non-neurogenic neurogenic bladder (the Hinman syndrome)-15 years later J Urol 136 769 772
36. I Mokhless S Gaafar K Fouda 2006 Botulinum A toxin urethral sphincter injection in children with nonneurogenic neurogenic bladder J Urol 176 1767 1770 10.1016/j.juro.2006.03.119
37. ZI Radojicic SV Perovic NM Milic 2006 Is it reasonable to treat refractory voiding dysfunction in children with botulinum-A toxin J Urol 176 332 336 10.1016/S0022-5347(06)00298-9
38. V Petronijevic M Lazovic M Vlajkovic 2007 Botulinum toxin type A in combination with standard urotherapy for children with dysfunctional voiding J Urol 178 2599 2602 10.1016/j.juro.2007.08.027